Arrogene

About:

Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.

Website: http://arrogene.com

Twitter/X: Arrogene

Description:

Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano-medicine platform that delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, enabling patients to prevent tumor growth for imaging.

Total Funding Amount:

$7.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Santa Monica, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)arrogene.com

Founders:

Alexander Ljubimova, Eggehard Holler

Number of Employees:

1-10

Last Funding Date:

2018-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai